Introduction
Many cellular and viral mRNAs, including those which encode the early antigens of polyomaviruses, are formed by alternative splicing (Leffet al., 1986) . In this process, several mature mRNA molecules are generated from one precursor transcript by the use of different combinations of splice donor and acceptor sites. For instance, the mRNA molecules encoding the large T and small t antigens of simian virus 40 (SV40) are formed by the selective use of two splice donor sites in combination with a single splice acceptor site (Fig. I a; Noble et al., 1986) .
In the nucleotide sequence of the early region of bovine polyomavirus (BPyV; ; EMBL/GenBank/DDBJ accession number D00755), several stretches of nucleotides have been identified that exhibit close similarity to the splice site consensus sequences defined by Mount (1982) . After translation of each of the potential spliced mRNAs into protein, the sizes of the encoded proteins and their similarity to those of other polyomaviruses were compared. Based on these results, it was determined whether a splice site could be a potential candidate for use in the splicing of BPyV early pre-mRNA molecules. As a result, it was proposed that the BPyV early region would be organized as outlined in Fig. 1 (b) ). In the current report, splice junctions present in the BPyV early mRNA molecules were mapped using reverse transcriptionpolymerase chain reaction (RT-PCR) and subsequent sequencing of the amplification products. Furthermore, the splicing pattern observed in BPyV-transformed murine cells was compared to that observed in permissively infected monkey kidney ceils. The results of these experiments indicate that the organization of the early region of BPyV is different to that anticipated . BPyV large T antigen seems to be encoded by an mRNA molecule assembled from three exons. No evidence was obtained for the presence of an mRNA molecule encoding a protein of a size approximating that of the small t antigens encoded by other polyomaviruses. R. Schuurman 
and others
Earle's salts and 2% Ultroser-G (Gibco) in lieu of foetal calf serum (FCS) .
Cell cultures of embryonic mouse cells (ME cells) and embryonic mouse cells transformed by the early region of bovine polyomavirus (ME-RBPy clones l, 2 and 3; Schuurman et al., 1992) were cultured in Iscove's modified Dulbecco's medium supplemented with 8% FCS. The FCS used for cell culture had previously been screened for the presence of BPyV using a BPyV-specific PCR assay (Schuurman et al., 1991) .
Total cellular RNA isolation. Isolation of RNA from cells cultured in vitro was performed essentially as described by Chirgwin et al. (1979) . Six days after infection, when cytopathology was observed throughout the cell culture, total cellular RNA was isolated from monkey kidney cells infected with BPyV (0-1 TCIDso/cell). Total cellular RNA was also isolated from subconfluent cultures of either BPyV-transformed murine embryo cells (Schuurman et al., 1992) or from untransformed (ME) cells.
Amplification primers. The location and sequence of the primers used in RT and amplification reactions are presented in Fig. 1 (d and e) . Each primer contained at least 20 nucleotides complementary to the BPyV genome. The 5' ends of all three primers contained a naturally occurring or an engineered restriction enzyme recognition sequence to enable cloning of the amplification products into a plasmid vector. The primers were synthesized using an Applied Biosystems synthesizer (model 381A).
R T and amplification procedure.
RT reactions were performed in 20 gl volumes using 100 ng of either primer r120 or r55. The reaction mixture consisted of 75 mM-KCI, 50 mM-Tris-HCl pH 8-3, 3 mM-MgC1 z, 10 mM-DTT, 1 mM each of four dNTPs, 20 units (U) of RNasin (Boehringer Mannheim), 5 U avian myeloblastosis virus reverse transcriptase (Boehringer Mannheim) and 1 to 3 ~tg of total cellular RNA. RT reactions were incubated at 42 °C for 60 min. Subsequently, the reaction vessels were incubated at 95 °C for 5 min to inactivate the enzyme. Thereafter, 80 ~tl of 1 x PCR buffer containing 50 mM-Tris-HCI pH 8-3, 25 mM-KCI, 2 mM-MgCI2, 100 p~g/ml BSA (Boehringer Mannheim), 100 ng of the 5' primer (1120) and 1 U of AmpliTaq DNA polymerase (Cetus) was added to the reaction mixtures. Amplification reactions were performed using a thermal cycler (Perkin-Elmer Cetus) according to the following procedure. After 5 min of denaturation at 95 °C, 35 amplification cycles were performed (1 min at 95 °C, 1 min at 55 °C, 2 min at 72 °C), followed by a final incubation at 72 °C for 8 min. Subsequently, 10% of the amplified material was analysed on a 2% agarose gel containing ethidium bromide, using the Tris-acetate-EDTA buffer system (Maniatis et al., 1982) . A 123 bp ladder (Gibco) was used as a size marker.
Cloning and sequencing of amplification products. Amplification products were excised from the agarose gels and subsequently purified using guanidinium isothiocyanate and silica particles, as described by Boom et al. (1990) . After digestion with BamHI and EcoRI, the fragments were cloned into pGEM-7 (Promega) and subsequently sequenced using Sequenase 2.0 (United States Biochemicals) according to the protocol described by Schuurman & Keulen (1990) .
Results

Analysis of BPyV early mRNA splice sites by RT-PCR
Based on the nucleotide sequence of BPyV, it has been suggested that the genes encoding the putative large T and small t antigens contain an intron sequence (a) Buchman et al. (1981) ; numbering of BPyV is according to . Thick lines represent protein-coding sequences, thin lines non-coding and intron sequences. Roman numerals above the sequences represent the reading frames used in mRNA translation. Open boxes below the antigens represent the HPDKGG motif described in the text. AAAA, polyadenylation signal sequence. (a) Genetic organization of the early region of SV40. (b) Proposed genetic organization of the early region of BPyV as described by . (c) Genetic organization of the early region of BPyV as determined experimentally (this study). (d) Schematic location of the primers used for reverse transcription (r120 and r55) and subsequent amplification (r120, r55 and 1120) of BPyV early mRNA sequences. (e) Actual sequences of the primers used in RT-PCR experiments and their location on the BPyV genome. Letters in italics represent endonuclease recognition sequences. . Both mature mRNAs were expected to be formed through the use of different splice donor and acceptor sites (Fig. 1 b) . To determine the splice junctions present in the early transcripts of BPyV, the mRNA sequences encoded by the BPyV genome between nucleotides 4697 and 4297 were amplified using RT-PCR. Primer r120 was used to reverse transcribe early mRNA molecules isolated from either BPyVinfected monkey kidney cells or from murine cells transformed by the early region of the virus. The resulting cDNA molecules were amplified for 35 cycles using primers r120 and 1120 ( Fig. 1 d) . According to the model outlined in Fig. 1 (b) , this RT-PCR was expected to generate two amplification products of 162 and 338 nucleotides, originating from putative mRNA molecules encoding the large T and small t antigen respectively .
However, as shown in Fig. 2 , the 162 bp product could not be detected after RT and subsequent amplification of mRNA sequences isolated from BPyV-infected monkey kidney cells. Instead, an unexpected product of approximately 261 nucleotides was amplified. Additionally, a minor amplification product was detected which appeared to be approximately 338 nucleotides in size and therefore was expected to originate from the putative small t mRNA molecule. The amplification product of approximately 409 nucleotides, observed in reactions with and without reverse transcriptase, most probably originated from DNA molecules or from unspliced BPyV RNA molecules present in the sample. In addition, a very faint band was observed in reactions with reverse transcriptase which migrated slightly faster than the 409 bp product. We do not expect this amplification product to represent a spliced BPyV early mRNA product because no combination of potential splice donor and acceptor sites was theoretically capable of generating an amplification product of this size. Further evaluation of the nature of this minor amplification product was unsuccessful; several attempts to clone the fragment have failed.
Upon performing the RT-PCR using RNA isolated from three independent lines of BPyV-transformed murine cells, we observed an amplification product of approximately 261 nucleotides in each of the reactions with reverse transcriptase (Fig. 3) . No other amplification products were observed with any of these samples except the 409 bp full-length product which was observed in the reactions without reverse transcriptase.
The 261 bp RT-PCR product represents BPyV large T mRNA
Upon DNA sequence analysis of the 261 bp RT-PCR products amplified from either permissive BPyV infected cells or from BPyV-transformed cells, it appeared that two intron sequences had been spliced out ( Fig. 4a and 1 c). An intron of 71 nucleotides located between nucleotides 4574 and 4503 (intron I) was spliced out together with a second intron of 77 nucleotides, located 80 nucleotides further downstream between nucleotides 4423 and 4346 (intron II). The presence of both splice junctions in one and the same recombinant clone strongly suggests that both introns were excised from the same pre-mRNA molecule. The splice donor and acceptor sites surrounding intron I closely match the ME-ME-ME-ME RBPy-I RBPy-2 RBPy-3 Fig. 3 . Results of RT-PCR experiment performed with 1 to 3 ~tg of total cellular RNA isolated from three expanded colonies of BPyVtransformed embryonic murine cells (ME-RBPy cells) and from ME cells, cDNA synthesis was performed using primer r120. Subsequent amplification of cDNA molecules was performed for 35 cycles using primers r120 and 1120. Lanes 1 and 2, reactions with and without reverse transcriptase, respectively; lanes M, 123 bp ladder.
consensus sequences of splice donor and acceptor sites as defined by Mount (1982) , and correlated exactly with those expected to be used in the formation of the mRNA molecule encoding the putative BPyV small t antigen . To excise the 77 nucleotide intron II sequence from the early primary transcript, a R. Schuurman and others (a) 4697 ATG GAA TTA ACA IC? GAG GAA TAT GAG GAG CTT AGG GGG CTC ITA GGA ACC CCT GAT ATT MELISEEYEELRGLLG~PDI 4637 GGC AAT GCA GAT ACT TTG AAA AAG GCA ?TC CTG AAG GCA TGC AAG GTG CAT CAT CCA GAI
4446 GCT GCA AGT GCC ACT ACT AGC CAG GTT CCA GAA TAT GGC ACC TCA CAG ?GG GAA CAG TGG AASATTSQVPEYGTSQWEQW (Higgins & Sharp, 1988 was not observed in experiments in which RNA isolated from BPyV-transformed cells was used (Fig. 3) . The size of this amplification product indicates that it might represent the small t mRNA molecule (depicted in Fig.  1 b) from which the 71 nucleotide intron I sequence had been excised. However, nucleotide sequence analysis of several recombinant plasmids containing this amplification product demonstrated that in all clones a 332 bp insert instead of the expected 338 bp product was present, and that the 77 nucleotide intron II sequence had been removed ( Fig. 4b and 1 c) instead of intron I. In the RNA molecule observed, which will be referred to as splice II, the size and location of the excised intron correlates exactly with the 77 nucleotide intron II removed from the mRNA molecule encoding the putative BPyV large T antigen, as is schematically shown in Fig. 1 (c) . Translation of the nucleotide sequence encoded by this splice II molecule resulted in a protein with a maximum size of 45 amino acids (nucleotides 4697 to 4562; Fig. 4b and 1 c) . In analogy to the situation in 1 2 M 3 4 Fig. 6 . Results of an RT-PCR experiment performed with 1 to 3 ~tg of total cellular RNA isolated from BPy¥-infected monkey kidney cells. cDNA synthesis was performed using either primer r55 (lanes 1 and 2) or primer r120 (lanes 3 and 4). Subsequent amplification of the cDNA molecules was performed for 35 cycles in combination with primer 1120 for all reactions. Lane M, 123 bp ladder; lanes 2 and 4, reaction without reverse transcriptase; lanes I and 3, reaction with reverse transcriptase.
-
~l c o I/ (laroe T SV40 small t mRNA splicing, the intron sequence removed from the splice II molecule was located downstream of the translation termination codon (nucleotide 4561). As described, in none of the clones sequenced was an insert present that represented the proposed small t mRNA from which the 71 nucleotide intron I sequence had been removed. Since the ORF created by removing this intron sequence from the primary transcript potentially encodes a 124 amino acid protein, which could possibly represent BPyV small t antigen, additional experiments were performed to investigate the presence of this mRNA molecule in BPyV-infected cells. For this purpose, RT reactions were performed using primer r55, which is complementary to the central part of the intron II sequence. Since the nucleotide sequence recognized by this primer had been removed from mRNA molecules from which the intron II sequence had been excised, splice II and splice I/II mRNA molecules could not be reverse transcribed using r55.
Upon performing an RT reaction with primer r55 to synthesize BPyV cDNA from RNA sequences isolated from permissively infected monkey kidney ceils, followed by 35 cycles of PCR amplification using primers r55 and 1120, we observed a single amplification product of 320 nucleotides, originating from either unspliced mRNA or from DNA (Fig. 6) . No amplification product of 249 bp, expected to originate from a small t antigenencoding transcript, was observed. In parallel control amplification reactions using primers r120 and 1120, minor reaction products of about 332 to 338 nucleotides were again observed. These experiments indicate that the concentration of splice I RNA, if it exists, is probably low when compared to that of splice II and splice I/II transcripts. (1990) ; in this map, the early region of the genome has been modified according to the present results. Nucleotide numbering is according to . Putative first and last protein-coding nuc|eotides are indicated.
Organization of the BPyV genome
The results of the experiments described in this paper constitute evidence that the organization of the gene encoding the large T antigen of BPyV is quite different from that of the SV40 gene and from the model proposed by . Therefore, the physical map of the BPyV genome was modified, as is shown in Fig. 7 . Whether the splice II mRNA molecule is translated in BPyV-infected cells is not known. For this reason, the splice II transcript has not been designated as encoding a specific antigen.
Discussion
The genetic organization of the BPyV large T antigen appears to differ from the general organization of genes encoding polyomaviral large T antigens. In contrast to the characteristic presence of only one intron of 250 to 400 nucleotides, two small introns (introns I and II) separated by an 80 nucleotide exon sequence have been identified in the gene encoding BPyV large T antigen. The most upstream splice donor site used in BPyV early mRNA splicing is located at position 4574 and, in combination with the acceptor site at position 4503, is involved in the removal of the 71 nucleotide intron I R. Schuurman and others sequence. For mRNA maturation, another, not previously predicted , splice donor site located at position 4424 was involved. This donor site is used in combination with the acceptor site at position 4346, thereby removing the 77 nucleotide intron II sequence from the primary transcript. The splice donor site at position 4424 (5' CAGIGUAuGg 3') matches the consensus sequence for splice donor sites (5' MAG[GUAAGU 3') defined by Mount (1982) at six of eight positions (indicated by capital letters), and is identical at the most critical nucleotides, those flanking the exon-intron junction.
Upon alignment of the sequences of the large T antigens of BPyV and SV40, as shown in Fig. 5 , highly conserved sequence motifs could be identified in several regions of the proteins, excluding the C-terminal part of the SV40 large T antigen. About 64 amino acid residues encoded by the SV40 C-terminal region are most probably not encoded by the BPyV genome. In SV40, this region is thought to contain a host range control element and a so-called adenovirus helper function, and to be involved in capsid assembly (Pipas, 1985; Tornow et al., 1985; Khalili et al., 1988; Cole et al., 1979) . The single transcription termination and polyadenylation signal (AAUAAA) present on the BPyV early coding strand is located only 48 nucleotides downstream of the translation termination codon proposed to be used in large T antigen production. We do not expect splicing in this region, for which no apparent or degenerate splice sites could be identified, to add amino acid residues to the large T antigen of BPyV. The 619 amino acidencoding ORF of the splice I/II mRNA was expected to encode a protein of approximately 70K. This has recently been proven by Western blotting (Schuurman et al., 1992) .
One of the two introns excised for the formation of the putative large T antigen mRNA molecule, the 71 nucleotide intron I, had previously been postulated to be involved in the formation of the putative small t antigen mRNA molecule Fig. 1 b) . Splicing intron I but not intron II from the early premRNA molecule would generate a RNA molecule with an ORF with the potential capacity to encode 124 amino acids. However, no experimental proof for the presence of this small t mRNA was obtained from the experiments presented. Whenever the mRNA molecule encoding the putative small t antigen was present in the BPyVinfected cells used for mRNA isolation, its concentration was probably very low compared to that of the splice I/II and splice II molecules.
Besides the splice I/II mRNA product, a splice II mRNA product, from which only the 77 nucleotide intron II sequence had been removed, was detected in permissively infected cells. It is not known whether the splice II mRNA molecule, which contains an ORF encoding 45 amino acid residues, is actually translated in BPyV-infected cells. However, all experiments performed to identify the splice sites in the early mRNA molecules of BPyV were performed on total cellular RNA. Therefore, the possibility that the splice II mRNA molecule is a relatively abundant nuclear intermediate in the formation of the mature large T mRNA molecule, for which both intron sequences have to be removed, cannot be excluded.
Apart from the splice I/II molecule, no additional early transcripts were detected in the three BPyVtransformed murine cell lines, suggesting that transformation of these cells can be achieved by BPyV large T antigen only. However, the possibility that other viral early antigens encoded by mRNA molecules of low abundance are synthesized in these cells cannot be excluded. In all experiments performed, the strength of the signal of the observed amplification product of large T mRNA molecules isolated from BPyV-transformed murine cells was at least equal to that observed with similar quantities of RNA isolated from permissively infected cells. Therefore, the relative concentration of the splice II molecules and other potential early viral transcripts was most probably lower in BPyV-transformed cells than in permissively infected cells. A mRNA molecule that would encode a small t-like protein could also have been missed using primers r120 and 1120, in cases in which a splice acceptor site located downstream of the 3' primer (rl20) was used. However, no amino acid sequence homology with SV40 small t antigen could be identified in any of the sequences encoded by the reading frames downstream of the 3' primer.
Some clearly defined functional domains of the SV40 large T antigen seem to be well conserved in the BPyV large T antigen, domains a to d in Fig. 5 . Domain b has been shown to be involved in the interaction between SV40 large T antigen and at least two cellular proteins: the product of the retinoblastoma tumour suppressor gene (pRB; DeCaprio et al., 1988) and p107 (Dyson et al., 1989; Ewen et al., 1989) . Although no experimental evidence has yet been obtained, the presence of a pRBbinding domain in the BPyV large T antigen strongly suggests that the latter is capable of complexing with pRB. Such an interaction might be an important step in cell transformation (Chen & Paucha, 1990) . In this respect, it is worth mentioning that primary rodent cells can be transformed by the early gene products of BPyV (Schuurman et al., 1992) .
Apart from a putative pRB-binding domain, a wellconserved nuclear localization signal can be identified in the BPyV large T antigen between residues 120 and 126 (Kalderon et al., 1984) ; and an amino acid sequence containing some characteristics of a zinc finger motif is located between 292 and 307 (Loeber et al., 1989) . Furthermore, a high degree of amino acid conservation in BPyV large T antigen was observed in the sequences flanking both sides of the splice junction between exons 1 and 2, as well as in the sequences immediately downstream of the junction between exons 2 and 3 (Fig.  5) . In this respect, it is worth mentioning that splicing out intron I from the BPyV early pre-mRNA sequence creates an amino acid motif (HPDKGG) which is completely conserved in the large T, small t and middle T antigen sequences of all polyomaviruses sequenced. The HPDKGG motif is located in the BPyV large T antigen between residues 38 and 43.
Two cellular proteins with Mrs of 61K and 37K have been shown to associate with the small t antigens of SV40 (Yang et al., 1979) and human polyomavirus BK (Rundell et al., 1981) , and with the small t and middle T antigens of polyomavirus (Grussenmayer et al., 1985; Pallas et al., 1988) . As has been demonstrated recently, these two proteins represent the regulatory (A) and catalytic (C) subunit of the protein phosphatase 2A (PP2A; Pallas et al., 1990; Walter et al., 1990) . The interaction of SV40 small t antigen with a complex of PP2A subunits A and C inhibits the catalytic activity of the C subunit (Yang et al., 1991) . Inhibition of PP2A activity is also achieved upon binding of the 55K B subunit to the AC complex of PP2A, indicating that the interaction of either SV40 small t antigen or the B subunit of PP2A with the AC complex might have analogous effects on enzyme activity (Yang et al., 1991) .
From comparisons between mouse polyomavirus small t antigen and the sequence of PP2A subunit B, no regions of significant amino acid sequence homology were noted (Pallas et al., 1992) . However, we detected a stretch of four amino acids (DKGG) in the sequence of the B subunits of PP2A proteins originating from several mammalian species which is the same as the four Cterminal residues of the aforementioned polyomavirus HPDKGG motif. Whether the presence of this sequence motif explains in part the common effect of small t antigen and PP2A subunit B on PP2A activity is not known. When the BPyV splice II molecule is translated, an HPDKGK motif is created. The C-terminal residue of the DKGG motiL a neutral glycine residue, is replaced by a polar lysine (K). Such a change could have dramatic influence on the function of the HPDKGG module. Although the HPDKGG motif is also present in the amino acid sequences of the large T antigens of all other polyomaviruses, no interactions of these antigens with the PP2A subunits have been reported. It might be possible that the motif is hidden within the threedimensional structure of large T antigens, thereby making it inaccessible to interaction with the PP2A
subunits. An interaction of the PP2A subunits with the mouse polyomavirus middle T antigen has been observed previously (Pallas et al., 1990; Walter et al., 1990) , indicating that in this case PP2A interacts with a viral early antigen which has been shown to play a crucial role in mouse polyomavirus-mediated cell transformation. It is important to note that the HPDKGG sequence present in BPyV large T antigen is created by joining the first and the second exon. This phenomenon, together with the apparently very high degree of intraspecies conservation of the motif in the early antigens, suggests an essential role for this sequence in the virus life cycle, and perhaps also for cell transformation. It could be speculated that BPyV large T antigen, like mouse polyomavirus middle T antigen, might be capable of interacting with PP2A, thereby taking over the function otherwise performed by small t antigen.
